Effexor side effects
Pro Research Analysisby 
Searched over 200M research papers
Effexor Side Effects: A Comprehensive Overview
Effexor (venlafaxine hydrochloride) is a widely prescribed antidepressant used to treat conditions such as depression, generalized anxiety disorder (GAD), social anxiety disorder, and panic disorder. While it is effective for these conditions, it is important to be aware of its potential side effects.
Common Side Effects of Effexor
Gastrointestinal Issues: Nausea and Vomiting
One of the most frequently reported side effects of Effexor is gastrointestinal discomfort, including nausea and vomiting. These symptoms are often observed when patients first start taking the medication or when their dosage is increased 12.
Nervous System Effects: Dizziness and Insomnia
Effexor can cause dizziness and insomnia in some patients. These side effects are significant enough to lead to drug discontinuation in a small percentage of cases. In clinical trials, insomnia and nervousness led to discontinuation in 0.9% of patients treated for depression and in 3-5% of patients treated for GAD 13.
Sweating and Dry Mouth
Increased sweating and dry mouth are also common side effects associated with Effexor. These symptoms can be bothersome but are generally not severe enough to require discontinuation of the medication 2.
Serious Side Effects
Cardiovascular Concerns: Sustained Hypertension
Effexor has been associated with sustained increases in blood pressure. In premarketing studies, 3% of patients treated for depression and 0.4% of patients treated for GAD experienced sustained hypertension. Regular monitoring of blood pressure is recommended for patients on Effexor, and dose reduction or discontinuation should be considered if sustained increases in blood pressure occur 13.
Neurological Effects: Seizures and Mania
Seizures have been reported in 0.3% of patients in premarketing depression trials. Effexor should be used cautiously in patients with a history of seizures, and the medication should be discontinued if seizures develop. Additionally, mania or hypomania has been observed in some patients during short-term depression studies, necessitating cautious use in patients with a history of mania 13.
Hyponatremia and Mydriasis
Hyponatremia, or low sodium levels in the blood, and mydriasis, or dilation of the pupils, have been reported with Effexor use. These conditions require careful monitoring, especially in elderly patients or those taking diuretics 13.
Abnormal Bleeding
Effexor may increase the risk of abnormal bleeding, particularly in patients predisposed to bleeding disorders. This is a concern shared with other serotonin-reuptake inhibitors 13.
Rare but Severe Side Effects
Impaired Detrusor Contractility
A rare but serious side effect of Effexor is impaired detrusor contractility, which affects bladder function. This condition has been reported to resolve upon discontinuation of the drug 2.
Interaction with Monoamine Oxidase Inhibitors (MAOIs)
Effexor should not be used in combination with MAOIs or within 14 days of discontinuing an MAOI due to the risk of serious, potentially fatal reactions. These reactions can include tremor, myoclonus, diaphoresis, hyperthermia, seizures, and even death 13.
Conclusion
Effexor is an effective treatment for various anxiety and depressive disorders, but it comes with a range of potential side effects. Common side effects include gastrointestinal issues, dizziness, and sweating, while more serious side effects can involve cardiovascular, neurological, and metabolic concerns. Patients should be closely monitored, especially during the initial stages of treatment and when adjusting dosages. Always consult with a healthcare provider to weigh the benefits and risks of Effexor in your specific case.
Sources and full results
Most relevant research papers on this topic
Impaired detrusor contractility due to venlafaxine use
Venlafaxine use can cause impaired detrusor contractility, which resolves after discontinuing the drug.
Case ReportVenlafaxine hydrochloride (EffexorTM) relieves thermal hyperalgesia in rats with an experimental mononeuropathy 1 1 This study was presented in abstract form at the 1995 Annual Meeting of the American Society of Anesthesiologists in Atlanta, Georgia.
Venlafaxine hydrochloride (Effexor) effectively relieves thermal hyperalgesia in rats with neuropathic pain due to chronic constriction injury of the sciatic nerve, without causing sedation.
RCT
Animal StudyAcupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial.
Acupuncture is a safe, effective, and durable treatment for vasomotor symptoms related to long-term antiestrogen hormone use in breast cancer patients, with fewer adverse effects than venlafaxine.
RCT
Rigorous Journal
Highly CitedEffexor XR
Antidepressants increase the risk of suicidality in children, adolescents, and young adults, but short-term studies show no increase in this risk in adults beyond age 24 and a reduction in risk in adults aged 65 and older.
An Open Treatment Trial of Venlafaxine for Elderly Patients With Dysthymic Disorder
Venlafaxine shows high response rates and generally good tolerability in elderly patients with dysthymic disorder.
The antidepressants venlafaxine ("Effexor") and fluoxetine ("Prozac") produce different effects on locomotion in two species of marine snail, the oyster drill (Urosalpinx cinerea) and the starsnail (Lithopoma americanum).
Venlafaxine boosts snail locomotion while fluoxetine reduces it, both preludes to foot detachment in marine snails.
Non-RCTAnimal Study